Neogen Shares Outstanding 2010-2025 | NEOG
Neogen shares outstanding from 2010 to 2025. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
| Neogen Annual Shares Outstanding (Millions of Shares) |
|
|---|---|
| 2024 | 216 |
| 2023 | 189 |
| 2022 | 108 |
| 2021 | 107 |
| 2020 | 106 |
| 2019 | 105 |
| 2018 | 104 |
| 2017 | 102 |
| 2016 | 101 |
| 2015 | 100 |
| 2014 | 99 |
| 2013 | 97 |
| 2012 | 96 |
| 2011 | 95 |
| 2010 | 92 |
| 2009 | 90 |
| Neogen Quarterly Shares Outstanding (Millions of Shares) |
|
|---|---|
| 2025-02-28 | 217 |
| 2024-11-30 | 217 |
| 2024-08-31 | 217 |
| 2024-05-31 | 216 |
| 2024-02-29 | 217 |
| 2023-11-30 | 216 |
| 2023-08-31 | 217 |
| 2023-05-31 | 189 |
| 2023-02-28 | 216 |
| 2022-11-30 | 216 |
| 2022-08-31 | 108 |
| 2022-05-31 | 108 |
| 2022-02-28 | 108 |
| 2021-11-30 | 108 |
| 2021-08-31 | 108 |
| 2021-05-31 | 107 |
| 2021-02-28 | 107 |
| 2020-11-30 | 107 |
| 2020-08-31 | 107 |
| 2020-05-31 | 106 |
| 2020-02-29 | 106 |
| 2019-11-30 | 106 |
| 2019-08-31 | 105 |
| 2019-05-31 | 105 |
| 2019-02-28 | 105 |
| 2018-11-30 | 105 |
| 2018-08-31 | 106 |
| 2018-05-31 | 104 |
| 2018-02-28 | 104 |
| 2017-11-30 | 104 |
| 2017-08-31 | 103 |
| 2017-05-31 | 102 |
| 2017-02-28 | 103 |
| 2016-11-30 | 102 |
| 2016-08-31 | 102 |
| 2016-05-31 | 101 |
| 2016-02-29 | 101 |
| 2015-11-30 | 101 |
| 2015-08-31 | 101 |
| 2015-05-31 | 100 |
| 2015-02-28 | 100 |
| 2014-11-30 | 100 |
| 2014-08-31 | 99 |
| 2014-05-31 | 99 |
| 2014-02-28 | 99 |
| 2013-11-30 | 100 |
| 2013-08-31 | 99 |
| 2013-05-31 | 97 |
| 2013-02-28 | 98 |
| 2012-11-30 | 97 |
| 2012-08-31 | 97 |
| 2012-05-31 | 96 |
| 2012-02-29 | 96 |
| 2011-11-30 | 96 |
| 2011-08-31 | 96 |
| 2011-05-31 | 95 |
| 2011-02-28 | 96 |
| 2010-11-30 | 95 |
| 2010-08-31 | 94 |
| 2010-05-31 | 92 |
| 2010-02-28 | 93 |
| 2009-11-30 | 92 |
| 2009-08-31 | 92 |
| 2009-05-31 | 90 |
| 2009-02-28 | 91 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $1.090B | $0.924B |
| Neogen Corp. develops and markets food and animal safety products. Its Food Safety Division markets culture media and diagnostic test kits to detect foodborne bacteria, natural toxins, food allergens, drug residues, plant diseases and sanitation concerns. Neogen has 2 business segments: Food Safety and Animal Safety. Food Safety: The products in the segment include tests for Mycotoxins, Food allergens, Dairy antibiotics, Foodborne pathogens, Spoilage microorganisms, Sanitation monitoring, Dehydrated culture media and Seafood contaminants. Animal Safety: The division is engaged in the development, manufacture, marketing and distribution of veterinary instruments, pharmaceuticals, vaccines, topicals, diagnostic products, rodenticides, cleaners, disinfectants, insecticides and genomics testing services for the worldwide animal safety market. These products are marketed via national & international distributors and farm supply retail chains in the U.S. and Canada. It acquired Delta Genomics Centre in Canada. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $218.750B | 25.66 |
| Boston Scientific (BSX) | United States | $152.620B | 38.21 |
| Stryker (SYK) | United States | $150.824B | 31.54 |
| EssilorLuxottica (ESLOY) | France | $131.932B | 0.00 |
| Medtronic (MDT) | Ireland | $117.545B | 16.66 |
| Lonza Group Ag (LZAGY) | Switzerland | $49.596B | 0.00 |
| Haleon (HLN) | United Kingdom | $43.351B | 24.74 |
| ResMed (RMD) | United States | $39.208B | 29.45 |
| GE HealthCare Technologies (GEHC) | United States | $35.024B | 16.63 |
| Agilent Technologies (A) | United States | $33.005B | 21.52 |
| Koninklijke Philips (PHG) | Netherlands | $24.092B | 16.91 |
| Terumo (TRUMY) | Japan | $23.645B | 30.71 |
| Insulet (PODD) | United States | $20.097B | 78.89 |
| Zimmer Biomet Holdings (ZBH) | United States | $19.096B | 12.26 |
| Baxter (BAX) | United States | $14.117B | 10.54 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.547B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $10.417B | 0.00 |
| Demant (WILYY) | Denmark | $8.633B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.680B | 23.25 |
| Lantheus Holdings (LNTH) | United States | $5.005B | 12.62 |
| Perrigo (PRGO) | Ireland | $3.788B | 9.60 |
| Prestige Consumer Healthcare (PBH) | United States | $3.776B | 16.87 |
| Haemonetics (HAE) | United States | $3.565B | 16.24 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Envista Holdings (NVST) | United States | $3.397B | 28.23 |
| ICU Medical (ICUI) | United States | $3.107B | 22.91 |
| LeMaitre Vascular (LMAT) | United States | $1.816B | 40.60 |
| QuidelOrtho (QDEL) | United States | $1.727B | 11.88 |
| AtriCure (ATRC) | United States | $1.454B | 0.00 |
| Acuren (TIC) | United States | $1.435B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.279B | 12.99 |
| Green Thumb Industries (GTBIF) | United States | $1.243B | 27.96 |
| Phibro Animal Health (PAHC) | United States | $1.185B | 15.15 |
| BioLife Solutions (BLFS) | United States | $1.024B | 0.00 |
| InMode (INMD) | Israel | $0.911B | 9.18 |
| Kestra Medical Technologies (KMTS) | United States | $0.874B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.791B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.784B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.644B | 0.00 |
| Owens & Minor (OMI) | United States | $0.626B | 5.19 |
| Evolus (EOLS) | United States | $0.617B | 0.00 |
| CeriBell (CBLL) | United States | $0.561B | 0.00 |
| Valneva SE (VALN) | France | $0.530B | 0.00 |
| ZimVie (ZIMV) | United States | $0.522B | 23.71 |
| Surmodics (SRDX) | United States | $0.456B | 0.00 |
| SNDL (SNDL) | Canada | $0.431B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.315B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.312B | 11.48 |
| Cresco Labs (CRLBF) | United States | $0.307B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.303B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.298B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.284B | 84.17 |
| Quanterix (QTRX) | United States | $0.275B | 0.00 |
| Cerus (CERS) | United States | $0.273B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.258B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.257B | 21.67 |
| Canopy Growth (CGC) | Canada | $0.256B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.234B | 0.00 |
| Brainsway (BWAY) | Israel | $0.229B | 60.50 |
| Biote (BTMD) | United States | $0.225B | 6.34 |
| Verano Holdings (VRNOF) | United States | $0.220B | 0.00 |
| Omeros (OMER) | United States | $0.219B | 0.00 |
| Organigram Global (OGI) | Canada | $0.208B | 0.00 |
| High Tide (HITI) | Canada | $0.195B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.183B | 14.93 |
| TriSalus Life Sciences (TLSI) | United States | $0.170B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.153B | 0.00 |
| Exagen (XGN) | United States | $0.148B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.124B | 15.32 |
| TerrAscend (TSNDF) | Canada | $0.112B | 0.00 |
| Jin Medical (ZJYL) | China | $0.100B | 0.00 |
| Fonar (FONR) | United States | $0.099B | 12.77 |
| MacroGenics (MGNX) | United States | $0.097B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.096B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.087B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.086B | 0.00 |
| Apyx Medical (APYX) | United States | $0.085B | 0.00 |
| Veru (VERU) | United States | $0.084B | 0.00 |
| Safety Shot (SHOT) | United States | $0.081B | 0.00 |
| Zynex (ZYXI) | United States | $0.074B | 0.00 |
| InterCure (INCR) | Israel | $0.072B | 0.00 |
| Agape ATP (ATPC) | $0.068B | 0.00 | |
| Cytosorbents (CTSO) | United States | $0.063B | 0.00 |
| ImmuCell (ICCC) | United States | $0.062B | 0.00 |
| United-Guardian (UG) | United States | $0.044B | 15.11 |
| Rockwell Medical (RMTI) | United States | $0.039B | 0.00 |
| Modular Medical (MODD) | United States | $0.038B | 0.00 |
| Nephros (NEPH) | United States | $0.037B | 50.14 |
| Allurion Technologies (ALUR) | United States | $0.024B | 0.00 |
| INLIF (INLF) | $0.015B | 0.00 | |
| Flora Growth (FLGC) | United States | $0.015B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.013B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.013B | 0.00 |
| Senestech (SNES) | United States | $0.013B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.012B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| Sharps Technology (STSS) | United States | $0.006B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |